{"id":"NCT01967173","sponsor":"Milton S. Hershey Medical Center","briefTitle":"Best African American Response to Asthma Drugs","officialTitle":"Best African American Response to Asthma Drugs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02","primaryCompletion":"2017-07-01","completion":"2017-07-01","firstPosted":"2013-10-22","resultsPosted":"2018-11-15","lastUpdate":"2018-11-15"},"enrollment":574,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Flovent Diskus® 100 mcg","otherNames":[]},{"type":"DRUG","name":"Flovent Diskus® 250 mcg","otherNames":[]},{"type":"DRUG","name":"Flovent Diskus® 500 mcg","otherNames":[]},{"type":"DRUG","name":"Advair Diskus® 100/50 mcg","otherNames":[]},{"type":"DRUG","name":"Advair Diskus® 250/50 mcg","otherNames":[]}],"arms":[{"label":"Crossover sequence 1","type":"EXPERIMENTAL"},{"label":"Crossover sequence 2","type":"EXPERIMENTAL"},{"label":"Crossover sequence 3","type":"EXPERIMENTAL"},{"label":"Crossover sequence 4","type":"EXPERIMENTAL"},{"label":"Crossover sequence 5","type":"EXPERIMENTAL"},{"label":"Crossover sequence 6","type":"EXPERIMENTAL"},{"label":"Crossover sequence 7","type":"EXPERIMENTAL"},{"label":"Crossover sequence 8","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to find the best asthma treatment to add for Blacks who have asthma that is not well controlled on a low dose of inhaled steroid. This study will also try to find out if Black adults and children differ in how they respond to the medications used in this study.","primaryOutcome":{"measure":"The Primary Outcome is a Composite Measure That Uses Exacerbations, Asthma Control Days During the Last 12 of 14 Weeks of a Treatment Regimen, and Percent Predicted FEV1 at the End of a Treatment Regimen.","timeFrame":"The last 12 weeks of each 14-week treatment period","effectByArm":[{"arm":"Adolescents and Adults","deltaMin":0.49,"sd":null},{"arm":"Children","deltaMin":0.46,"sd":null}],"pValues":[{"comp":"OG000","p":"0.003"},{"comp":"OG001","p":"0.9"},{"comp":"OG000","p":"<0.001"},{"comp":"OG000","p":"0.42"},{"comp":"OG001","p":"0.84"},{"comp":"OG000","p":"0.015"},{"comp":"OG000","p":"0.085"},{"comp":"OG001","p":"0.62"},{"comp":"OG000","p":"0.48"},{"comp":"OG001","p":"0.14"},{"comp":"OG001","p":"0.096"}]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":28,"countries":["United States"]},"refs":{"pmids":["31553835"],"seeAlso":["http://asthmanetresearch.org/"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":280},"commonTop":["Asthma Exacerbation","Acute Nasopharyngitis","Acute Upper Respiratory Tract Infection","Cough","Fever"]}}